Custom Search

News

Thursday 01 April 2004

Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge.

By: Gray NS.

Hum Psychopharmacol 2004 Apr;19(3):205-7

A case of neuroleptic malignant syndrome (NMS) in a patient with Parkinson's disease (PD) is presented. The syndrome was precipitated by the atypical antipsychotic, ziprasidone. The challenge of recognizing NMS in a patient with underlying parkinsonian symptoms, where prominent symptom overlap can occur, is discussed. Copyright 2004 John Wiley & Sons, Ltd.

Use of this site is subject to the following terms of use